Alpha Tau Medical (DRTS) Total Current Liabilities (2020 - 2026)
Alpha Tau Medical (DRTS) posted Total Current Liabilities of $10.4 million for Q1 2026, down 0.56% sequentially from $10.5 million in Q4 2025, and up 6.98% YoY from $9.8 million in Q1 2025.
Alpha Tau Medical (DRTS) Total Current Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Total Current Liabilities for 7 years, with the latest figure at $10.4 million in Q1 2026.
- Quarterly Total Current Liabilities rose 6.98% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 6.98% YoY) and the FY2025 annual result came in at $10.5 million, up 21.12% from the prior year.
- Total Current Liabilities fell to $10.4 million in Q1 2026 per DRTS's latest filing, from $10.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $10.5 million in Q4 2025 and troughed at $2.8 million in Q2 2022.
- A 5-year average of $6.9 million and a median of $6.5 million in 2024 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 95.95% in 2023, down 15.36% in 2023.
- Over 5 years, Total Current Liabilities stood at $4.3 million in 2022, then soared by 63.72% to $7.1 million in 2023, then advanced by 22.15% to $8.7 million in 2024, then climbed by 21.12% to $10.5 million in 2025, then fell by 0.56% to $10.4 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $10.4 million, $10.5 million, and $9.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.63 Mn |
| Mar 31, 2026 | 10.45 Mn |
| Dec 31, 2025 | 10.51 Mn |
| Sep 30, 2025 | 9.14 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | 9.77 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 6.35 Mn |
| Jun 30, 2024 | 6.46 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 6.24 Mn |
| Jun 30, 2023 | 5.42 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 4.34 Mn |
| Sep 30, 2022 | 3.35 Mn |
| Jun 30, 2022 | 2.76 Mn |
| Mar 31, 2022 | 6.30 Mn |
| Dec 31, 2021 | 4.41 Mn |
| Dec 31, 2020 | 2.09 Mn |